• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Eiger BioPharmaceuticals

edit

Eiger BioPharmaceuticals is developer of treatments for strains of hepatitis.

Milestones

edit

• 
  Eiger BioPharmaceuticals received $7.1M in Series A funding. (2/25/09)
  Posted 4/14/09 at 3:53am via venturebeat.com

Videos

Screenshots

edit

Sources

1. Eiger snaps up $7.1M to treat hepatitis (venturebeat.com) [edit]